Chapter/Section Purchase

Leave This Empty:

Global Viral Vector Purification Market Research Report 2024(Status and Outlook)

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viral Vector Purification
1.2 Key Market Segments
1.2.1 Viral Vector Purification Segment by Type
1.2.2 Viral Vector Purification Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Viral Vector Purification Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Viral Vector Purification Market Competitive Landscape
3.1 Global Viral Vector Purification Revenue Market Share by Company (2019-2024)
3.2 Viral Vector Purification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Viral Vector Purification Market Size Sites, Area Served, Product Type
3.4 Viral Vector Purification Market Competitive Situation and Trends
3.4.1 Viral Vector Purification Market Concentration Rate
3.4.2 Global 5 and 10 Largest Viral Vector Purification Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Viral Vector Purification Value Chain Analysis
4.1 Viral Vector Purification Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Viral Vector Purification Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Viral Vector Purification Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vector Purification Market Size Market Share by Type (2019-2024)
6.3 Global Viral Vector Purification Market Size Growth Rate by Type (2019-2024)
7 Viral Vector Purification Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vector Purification Market Size (M USD) by Application (2019-2024)
7.3 Global Viral Vector Purification Market Size Growth Rate by Application (2019-2024)
8 Viral Vector Purification Market Segmentation by Region
8.1 Global Viral Vector Purification Market Size by Region
8.1.1 Global Viral Vector Purification Market Size by Region
8.1.2 Global Viral Vector Purification Market Size Market Share by Region
8.2 North America
8.2.1 North America Viral Vector Purification Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vector Purification Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vector Purification Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vector Purification Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vector Purification Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Applied Biological Materials Inc.
9.1.1 Applied Biological Materials Inc. Viral Vector Purification Basic Information
9.1.2 Applied Biological Materials Inc. Viral Vector Purification Product Overview
9.1.3 Applied Biological Materials Inc. Viral Vector Purification Product Market Performance
9.1.4 Applied Biological Materials Inc. Viral Vector Purification SWOT Analysis
9.1.5 Applied Biological Materials Inc. Business Overview
9.1.6 Applied Biological Materials Inc. Recent Developments
9.2 Creative Biolabs
9.2.1 Creative Biolabs Viral Vector Purification Basic Information
9.2.2 Creative Biolabs Viral Vector Purification Product Overview
9.2.3 Creative Biolabs Viral Vector Purification Product Market Performance
9.2.4 Applied Biological Materials Inc. Viral Vector Purification SWOT Analysis
9.2.5 Creative Biolabs Business Overview
9.2.6 Creative Biolabs Recent Developments
9.3 Bio-Rad Laboratories, Inc.
9.3.1 Bio-Rad Laboratories, Inc. Viral Vector Purification Basic Information
9.3.2 Bio-Rad Laboratories, Inc. Viral Vector Purification Product Overview
9.3.3 Bio-Rad Laboratories, Inc. Viral Vector Purification Product Market Performance
9.3.4 Applied Biological Materials Inc. Viral Vector Purification SWOT Analysis
9.3.5 Bio-Rad Laboratories, Inc. Business Overview
9.3.6 Bio-Rad Laboratories, Inc. Recent Developments
9.4 Sirion-Biotech GmbH
9.4.1 Sirion-Biotech GmbH Viral Vector Purification Basic Information
9.4.2 Sirion-Biotech GmbH Viral Vector Purification Product Overview
9.4.3 Sirion-Biotech GmbH Viral Vector Purification Product Market Performance
9.4.4 Sirion-Biotech GmbH Business Overview
9.4.5 Sirion-Biotech GmbH Recent Developments
9.5 Merck KGaA
9.5.1 Merck KGaA Viral Vector Purification Basic Information
9.5.2 Merck KGaA Viral Vector Purification Product Overview
9.5.3 Merck KGaA Viral Vector Purification Product Market Performance
9.5.4 Merck KGaA Business Overview
9.5.5 Merck KGaA Recent Developments
9.6 FUJIFILM Diosynth Biotechnologies
9.6.1 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Basic Information
9.6.2 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Product Overview
9.6.3 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Product Market Performance
9.6.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.7 Batavia BiosciencesB.v.Agilent Technologies, Inc.
9.7.1 Batavia BiosciencesB.v.Agilent Technologies, Inc. Viral Vector Purification Basic Information
9.7.2 Batavia BiosciencesB.v.Agilent Technologies, Inc. Viral Vector Purification Product Overview
9.7.3 Batavia BiosciencesB.v.Agilent Technologies, Inc. Viral Vector Purification Product Market Performance
9.7.4 Batavia BiosciencesB.v.Agilent Technologies, Inc. Business Overview
9.7.5 Batavia BiosciencesB.v.Agilent Technologies, Inc. Recent Developments
9.8 ProBioGen AG
9.8.1 ProBioGen AG Viral Vector Purification Basic Information
9.8.2 ProBioGen AG Viral Vector Purification Product Overview
9.8.3 ProBioGen AG Viral Vector Purification Product Market Performance
9.8.4 ProBioGen AG Business Overview
9.8.5 ProBioGen AG Recent Developments
9.9 Takara Bio lnc.
9.9.1 Takara Bio lnc. Viral Vector Purification Basic Information
9.9.2 Takara Bio lnc. Viral Vector Purification Product Overview
9.9.3 Takara Bio lnc. Viral Vector Purification Product Market Performance
9.9.4 Takara Bio lnc. Business Overview
9.9.5 Takara Bio lnc. Recent Developments
9.10 Novartis
9.10.1 Novartis Viral Vector Purification Basic Information
9.10.2 Novartis Viral Vector Purification Product Overview
9.10.3 Novartis Viral Vector Purification Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Repligen
9.11.1 Repligen Viral Vector Purification Basic Information
9.11.2 Repligen Viral Vector Purification Product Overview
9.11.3 Repligen Viral Vector Purification Product Market Performance
9.11.4 Repligen Business Overview
9.11.5 Repligen Recent Developments
10 Viral Vector Purification Regional Market Forecast
10.1 Global Viral Vector Purification Market Size Forecast
10.2 Global Viral Vector Purification Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vector Purification Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vector Purification Market Size Forecast by Region
10.2.4 South America Viral Vector Purification Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vector Purification by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Viral Vector Purification Market Forecast by Type (2025-2030)
11.2 Global Viral Vector Purification Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings